Bullfrog Oil Reduces the Carrageenan-induced Edema in Wistar Rats by in vitro Reduction of Inflammatory Mediators
Open Access
- 1 January 2020
- journal article
- research article
- Published by Japan Oil Chemists' Society in Journal of Oleo Science
- Vol. 69 (2), 133-142
- https://doi.org/10.5650/jos.ess19215
Abstract
Bullfrog oil (BFO) is a natural product from the adipose tissue of the amphibian Rana catesbeiana Shaw, a bio-product rich in polyunsaturated fatty acids, which claims anti-inflammatory activity. The objective of this work was to evaluate the cytotoxicity and the anti-inflammatory activity of BFO using in vivo and in vitro assays. Thus, the in vitro cytotoxicity was assessed by the MTT assay. Additionally, the in vivo anti-inflammatory activity was performed by the carrageenan-induced paw edema model in Wistar rats, followed by histological analysis. Moreover, the BFO effect on inflammatory pathways was investigated by in vitro evaluation of the nitric oxide (NO) synthesis, and type-6 interleukin (IL-6) and tumor-necrosisfactor (TNF) levels. In vivo experiments showed that BFO administered by intragastric route produced a significant anti-inflammatory effect, which was as substantial as indomethacin, the positive control. Histopathological analysis confirmed these results, showing the absence of the edema and minimal signs of inflammation in the paws of rats treated with BFO. The MTT results showed that BFO at all tested concentrations had no toxic effect against a macrophage cell line, not affecting the cell viability. In addition, after 48 hours of treatment, the BFO itself and its blend with Cetiol®-V (1:1v/v) at 200 µg.mL–1 were able to reduce the NO synthesis, and the IL-6 and TNF levels up to 35 ± 2%, 40 ± 6%, and 12 ± 3%, respectively. Therefore, these results provide unprecedented scientific evidence of the anti-inflammatory effect of BFO, suggesting its potential as a new candidate for the development of pharmaceutical products with antiinflammatory activity.Keywords
This publication has 32 references indexed in Scilit:
- Formulation of sunscreens with enhancement sun protection factor response based on solid lipid nanoparticlesInternational Journal of Cosmetic Science, 2011
- Anticoagulant activity, paw edema and pleurisy induced carrageenan: Action of major types of commercial carrageenansCarbohydrate Polymers, 2010
- Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophagesJournal of Ethnopharmacology, 2009
- Polyunsaturated fatty acids and inflammationProstaglandins, Leukotrienes & Essential Fatty Acids, 2006
- Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cellsBiochemical and Biophysical Research Communications, 2005
- Expression of Concern: Carrageenan‐induced mouse paw oedema is biphasic, age‐weight dependent and displays differential nitric oxide cyclooxygenase‐2 expressionBritish Journal of Pharmacology, 2004
- Industrial use of lipases to produce fatty acid estersEuropean Journal of Lipid Science and Technology, 2003
- Effects of Anthocyanins and Other Phenolic Compounds on the Production of Tumor Necrosis Factor α in LPS/IFN-γ-Activated RAW 264.7 MacrophagesJournal of Agricultural and Food Chemistry, 2002
- Studies on Anti-Inflammatory Activity of Spice Principles and Dietary n-3 Polyunsaturated Fatty Acids on Carrageenan-lnduced Inflammation in RatsAnnals of Nutrition and Metabolism, 1994
- Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory DrugsExperimental Biology and Medicine, 1962